# Washington is Mobilizing Against Sepsis. But is it Enough? | Eliaz Therapeutics

- Canonical URL: https://wefunder.com/feed/184095
- Entity ID: wefunder:feed_item:184095
- Published at: 2025-07-24 20:57:37 UTC
- Updated at: 2025-07-24 20:57:44 UTC

## Author
Dr. Isaac Eliaz (MD)

## Subject
Eliaz Therapeutics

## Content
Dear friends,Last month, the U.S. Senate reintroduced the bipartisan SEPSIS Act1 to funnel national resources toward better care and data collection. This comes at a critical time in our fight against sepsis as new federal data shows a nearly 40% increase2 in sepsis hospitalizations between 2016 and 2021. This national spotlight is a significant step forward. But, as a physician who has watched families and patients fight what is often a lonely battle against an extremely deadly condition, I must ask—Is it enough?Awareness and better data are essential. But they cannot stop the biological storm that claims the lives of so many. We must have the tools that can address the root cause of the body’s own dysregulated inflammatory response. This is the very reason we developed XGal-3®It was engineered to be that missing tool, one which gently helps restore balance. This is a historic moment where awareness and innovation can finally meet. As an investor in Eliaz Therapeutics here on Wefunder, you are enabling us to answer this call. Thank you for helping our team meet the moment!Yours in health, Isaac Eliaz, MD, MS, LAc💡 Read to join us? Invest now: https://wefunder.com/eliaztherapeutics/invest 🖥️Citations:https://www.ahrq.gov/news/newsletters/e-newsletter/949.htmlhttps://www.endsepsis.org/2025/06/05/breaking-news-sepsis-act-reintroduced-in-us-senate/